Management of patients with menopausal metabolic syndrome

In the 21st century, two medical and demographic trends towards increased life expectancy and higher prevalence of obesity and metabolic syndrome (MS) have formed literally before our eyes. It is metabolic syndrome (often being an essential attribute of obesity) that entails a number of potential risks for not only endocrine and metabolic, but also somatic health. It has been proven that MS is a condition that potentiates the risk of developing a number of disease entities: cardiovascular to neurodegenerative. Furthermore, due to progressive hypoestrogenism, peri-and postmenopause are accompanied by the endocrine and metabolic reprogramming that significantly increases the risk of realization of the above disease entities. Hence, the aim of the paper is to consider the relevance of menopausal metabolic syndrome at present, as well as to cover the features of clinical management of patients in this cohort based on modern evidence-based data. © 2025, LLC MMA MediaMedika. All rights reserved.